Article

(2019) Effect of beta-D-Mannuronic Acid (M2000) on Oxidative Stress Enzymes' Gene Using Healthy Donor Peripheral Blood Mononuclear Cells for Evaluating the Anti-Aging Property. Current Drug Discovery Technologies. pp. 265-271. ISSN 1875-6220 (Electronic) 1570-1638 (Linking)

(2018) Evaluation of the efficacy and safety of beta-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial. International Immunopharmacology. pp. 112-117. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)

(2018) Oral administration effects of beta-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. pp. 495-500. ISSN 1950-6007 (Electronic) 0753-3322 (Linking)

(2017) Introduction of beta-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression. Pharmacological reports : PR. pp. 1067-1072. ISSN 2299-5684 (Electronic) 1734-1140 (Linking)